Drug affinity complex raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
Reviewed 2025-09-16. Anything still debated is marked as such rather than presented as settled.
Two related forms circulate in technical discussion under the same family name. The original version carries a drug affinity complex (DAC) that binds covalently to serum albumin after administration, and this linkage substantially extends circulation time. A second form, frequently written as modified GRF(1-29) or CJC-1295 without DAC, lacks that linker and clears much faster. The naming is a frequent source of confusion because the shorthand CJC-1295 can refer to either form depending on the source. Reports sometimes fail to specify which variant was studied.
The peptide backbone includes a D-alanine at position two, which resists cleavage by dipeptidyl peptidase IV, and several other substitutions that reduce degradation. Its molecular weight is roughly 3.4 kDa without the linker and about 3.6 kDa with it. The molecule is water soluble and is normally supplied as a lyophilized powder. Precise sequence and mass values depend on which variant is described, so technical documents usually state the exact form being referenced.
CJC-1295 is a synthetic peptide designed as a long-acting analogue of growth hormone-releasing hormone (GHRH). Its structure derives from the first 29 amino acids of native GHRH, a fragment often called GRF(1-29). Four substitutions were introduced to slow enzymatic breakdown and extend activity relative to the natural sequence. The compound was developed by ConjuChem as part of a broader effort to improve the pharmacokinetic profile of peptide hormones. It is studied in laboratory and clinical research settings rather than appearing as a naturally occurring substance.
CJC-1295 is a synthetic peptide built as a long-acting analogue of growth hormone-releasing hormone. Its backbone matches the first twenty-nine residues of the natural human hormone, with four amino acid substitutions added to slow enzymatic breakdown. A reactive maleimide group, commonly termed the drug affinity complex, allows the peptide to attach to circulating albumin after administration. That albumin attachment keeps the molecule in the bloodstream for an extended period instead of being cleared within minutes.
The compound emerged from work at a Canadian biotechnology firm in the early 2000s. Early human studies examined its effect on growth hormone and insulin-like growth factor 1 in healthy volunteers and in people with HIV-associated fat redistribution. Reports described sustained increases in both markers after a single injection. Development did not advance to regulatory approval, and the clinical programme was later discontinued. The molecule is now encountered mainly as a research chemical rather than a marketed medicine.
| Property | Value | Notes |
|---|---|---|
| Molecular weight (no linker) | ~3.37 kDa | Calculated from peptide sequence |
| Molecular weight (with linker) | ~3.65 kDa | Includes albumin-binding moiety |
| Appearance | White to off-white powder | Typically lyophilized |
| Solubility | Soluble in water | Also dissolves in aqueous buffers |
| Common synonyms | Modified GRF(1-29), DAC:GRF | Usage varies by source |
Lyophilised powder is the usual supplied form. The material is hygroscopic, so vials are typically equilibrated to room temperature before opening in order to prevent condensation on the contents. Long-term storage is generally described at minus twenty degrees Celsius or colder, protected from light and moisture. Repeated freeze-thaw cycles are avoided because they promote aggregation and loss of soluble material. A reconstituted solution is considerably less stable than the dry powder and is normally kept refrigerated for short periods only.
Identity and purity are assessed mainly by reversed-phase high-performance liquid chromatography combined with mass spectrometry. The chromatographic separation resolves the target peptide from truncation products and from species carrying oxidised residues, while mass measurement confirms the expected molecular mass. Because the two common variants differ by roughly 280 daltons, a mass determination distinguishes them unambiguously. Purity is often quoted as a percentage of total peak area, although that figure depends on the detection wavelength and the integration method applied.
Reported half-lives differ widely between the two variants and between species. Values for the albumin-binding form are usually expressed in days, while the unconjugated form is measured in minutes to a few hours. Sampling schedules, assay sensitivity, and route of administration all influence the numbers, which limits direct comparison across studies. Whether sustained receptor occupancy produces different downstream effects from pulsatile stimulation remains an open question in the published work. Claims about relative potency should therefore be read alongside the specific study design that produced them.
CJC-1295 is the name used for a synthetic peptide modeled on growth hormone-releasing hormone, the hypothalamic signal that prompts the pituitary to release growth hormone. The compound was described by a Canadian drug discovery company in the mid-2000s as a long-acting research tool. Two closely related molecules share the name in practice: one carries a drug affinity complex, or DAC, group, and one does not. The distinction matters because the two behave differently in circulation.
The peptide backbone corresponds to GRF(1-29), the first 29 residues of native growth hormone-releasing hormone, which retains most of the receptor-activating activity of the full-length molecule. Four substitutions distinguish the analog from the natural sequence: D-alanine at position 2, glutamine at position 8, alanine at position 15, and leucine at position 27. These changes slow cleavage by dipeptidyl peptidase IV, the enzyme that degrades native hormone in plasma within minutes. The outcome is improved enzymatic stability combined with a still brief residence time when no additional modification is present.
The drug affinity complex is a maleimidopropionic acid group attached to a lysine side chain. It reacts with the free thiol of cysteine-34 on circulating albumin, forming a covalent bond. This conjugation keeps the peptide in the bloodstream and shields it from rapid renal filtration and proteolysis. Reported circulation half-lives for the albumin-bound form fall in the range of roughly six to nine days in early human studies.
Binding to GHRH receptors on pituitary somatotroph cells triggers cyclic AMP signaling and stimulates growth hormone synthesis and release. Because the peptide acts upstream of the pituitary, effects are mediated through endogenous growth hormone rather than direct receptor activation in peripheral tissues. Increases in insulin-like growth factor 1 are generally described as a downstream consequence. Most published human exposure data come from small early-stage studies, and the clinical significance of the pharmacokinetic profile remains incompletely characterized.
Analytical confirmation usually relies on reversed-phase high-performance liquid chromatography for purity and on liquid chromatography coupled to mass spectrometry for identity. Mass data reveal the expected molecular mass and can flag truncated or oxidized species. Amino acid analysis and peptide mapping provide sequence-level verification. Immunoassays are used in some biological matrices, but antibodies raised against one releasing-hormone analog may cross-react with another. Reported purity figures depend heavily on the method used, so comparisons between suppliers require matching the analytical approach.
The two variants differ dramatically in how long they persist in circulation. The form lacking the albumin-binding group has a plasma half-life measured in tens of minutes, comparable to the natural hormone fragment. The version carrying the drug affinity complex binds albumin and shows a half-life of roughly six to eight days in human studies. That figure comes from small trials that tracked hormone levels over extended periods. The physiological consequences of sustained versus pulsatile stimulation are still debated and the literature does not settle the point.
Lyophilized peptide powder is comparatively stable when kept dry, cold, and protected from light. Once dissolved, the molecule is vulnerable to deamidation, oxidation, and aggregation, with the rate depending on pH, buffer composition, and temperature. Alkaline conditions and repeated freeze-thaw cycles accelerate loss of the intact peptide. The methionine present in the native sequence is a known oxidation site, which is one reason it was replaced in the modified fragment. Suppliers typically recommend cold storage of solutions and use within a short window.
In order to excite surface plasmon polaritons in a resonant manner, one can use electron bombardment or incident light beam (visible and infrared are typical). The incoming beam has to match its momentum to that of the plasmon. In the case of p-polarized light (polarization occurs parallel to the plane of incidence), this is possible by passing the light through a block of glass to increase the wavenumber (and the momentum), and achieve the resonance at a given wavelength and angle. S-polarized light (polarization occurs perpendicular to the plane of incidence) cannot excite electronic surface plasmons. Electronic and magnetic surface plasmons obey the following dispersion relation:
== N == Robert Nalbandyan (1937–2002), Armenian protein chemist known for discovery of photosynthetic protein plantacyanin Sergey Nametkin (1976–1950), Russian organic chemist known the cracking of petrochemicals, and rearrangement of camphenes Louise Natrajan (PhD 2003), British chemist who ortks on actinide chemistry and luminescence spectroscopy Giulio Natta (1903–1979), Italian chemical engineer worked on high density polymers, 1963 Nobel Prize in Chemistry Costin Nenițescu (1902–1970), Romanian chemist who studied the oxidation of open-chain and aromatic hydrocarbons with chromic acid and chromic oxychloride Antonio Neri (1576–1614), Florentine priest, author of L’Arte Vetraria (The Art of Glass), the first general treatise on the systematics of glassmaking Walther Nernst (1864–1941), German physical chemist whose heat theorem led the way to the third law of thermodynamics, 1920 Nobel Prize in Chemistry John Alexander Reina Newlands (1837–1898), British analytical chemist, precursor of the periodic order of elements William Nicholson (1753–1815), British chemist and civil engineer, the first to achieve electrolysis Kyriacos Costa Nicolaou (born 1946), Cypriot-American chemist known for total synthesis of natural products Julius Nieuwland (1878–1936), Belgian and American prirest and chemist who worked on synthetic rubber Mathias Nilsson, Swedish physical and analytical chemist concerned with liquid NMR spectroscopy Alfred Nobel (1833–1896), Swedish chemist who invented dynamite and established the Nobel Prizes Ronald George Wreyford Norrish (1897–1978), British chemist known for flash photolysis and the Norrish reaction, 1967 Nobel Prize in Chemistry John Howard Northrop (1891–1987), American biochemist known for isolation, crystallization, and study of enzymes, proteins, and viruses; 1946 Nobel Prize in Chemistry Ryōji Noyori (born 1938), Japanese chemist, 2001 Nobel Prize in Chemistry for the study of chirally catalyzed hydrogenations Ralph Nuzzo (born 1954), American materials chemist known for work on the chemistry of materials, including processes that occur at surfaces and interfaces
=== Artificial ligaments === One of the most often torn ligaments in the body is the anterior cruciate ligament (ACL). The ACL is one of the ligaments crucial to knee stability and persons who tear their ACL often undergo reconstructive surgery, which can be done through a variety of techniques and materials. One of these techniques is the replacement of the ligament with an artificial material. Artificial ligaments are a synthetic material composed of a polymer, such as polyacrylonitrile fiber, polypropylene, PET (polyethylene terephthalate), or polyNaSS poly (sodium styrene sulfonate).
Sources: en.wikipedia.org
Biko is viewed as the "father" of the Black Consciousness Movement and the anti-apartheid movement's first icon. Nelson Mandela called him "the spark that lit a veld fire across South Africa", adding that the Nationalist government "had to kill him to prolong the life of apartheid". Opening an anthology of his work in 2008, Manning Marable and Peniel Joseph wrote that his death had "created a vivid symbol of black resistance" to apartheid that "continues to inspire new black activists" over a decade after the transition to majority rule. Johann de Wet, a professor of communication studies, described him as "one of South Africa's most gifted political strategists and communicators". In 2004 he was elected 13th in SABC 3's Great South Africans public poll. Although Biko's ideas have not received the same attention as Frantz Fanon's, in 2001 Ahluwalia and Zegeye wrote that the men shared "a highly similar pedigree in their interests in the philosophical psychology of consciousness, their desire for a decolonising of the mind, the liberation of Africa and in the politics of nationalism and socialism for the 'wretched of the earth'". Some academics argue that Biko's thought remains relevant; for example, in African Identities in 2015, Isaac Kamola wrote that Biko's critique of white liberalism was relevant to situations like the United Nations' Millennium Development Goals and Invisible Children, Inc.'s KONY 2012 campaign.
Xestospongia testudinaria is a species of barrel sponge in the family Petrosiidae. More commonly known as Giant Barrel Sponges, they have the basic structure of a typical sponge. Their body is made of a reticulation of cells aggregate on a siliceous scaffold composed of small spikes called spicules. Water is taken into the inner chamber of the sponge (known as the spongocoel) through ostia (small pores created by porocytes). Flagellated choanocytes line the inner chamber and help generate water currents through the sponge. Due to the amount of water that Great Barrel Sponges filter throughout their lifespan, they perform an important ecological role.
== Medical uses == Trifluridine eye drops are used for the treatment of keratitis and keratoconjunctivitis caused by the herpes simplex virus types 1 and 2, as well as for prevention and treatment of vaccinia virus infections of the eye. A Cochrane Systematic Review showed that trifluridine and aciclovir were a more effective treatment than idoxuridine or vidarabine, significantly increasing the relative number of successfully healed eyes in one to two weeks.
Sources: en.wikipedia.org
No. It is a synthetic analogue modeled on the first 29 residues of human GHRH. The substitutions and any linker are laboratory modifications rather than features of the endogenous peptide.
Early development used the albumin-binding form, and a shorter variant was later discussed under the same label. Because the two differ in half-life and handling, ambiguity arises whenever a source omits the variant designation.
The compound derives from that fragment but is not identical to it. The parent fragment lacks the stabilizing substitutions, so its degradation rate and duration of action differ noticeably.
It is a synthetic peptide analogue of growth hormone-releasing hormone. Four substitutions in its sequence make it more resistant to enzymatic degradation than the natural hormone. In the version carrying a drug affinity complex, the peptide binds albumin and remains in circulation for days.